Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of patients with acute decompensated heart failure. Little is known about the efficacy and safety of peritoneal dialysis in patients with acute decompensated heart failure complicated by acute cardiorenal syndrome.
Methods:
We randomly assigned a total of 88 patients with type 1 acute cardiorenal syndrome to a strategy of ultrafiltration therapy (44 patients) or tidal peritoneal dialysis (44 patients). The primary endpoint was the change from baseline in the serum creatinine level and left ventricular function represented as ejection fraction, as assessed 72 and 120 h after random assignment. Patients were followed for 90 days after discharge from the hospital.
Results:
Ultrafiltration therapy was inferior to tidal peritoneal dialysis therapy with respect to the primary endpoint of the change in the serum creatinine levels at 72 and 120 h (p = 0.041) and ejection fraction at 72 and 120 h after enrollment (p = 0.044 and p = 0.032), owing to both an increase in the creatinine level in the ultrafiltration therapy group and a decrease in its level in the tidal peritoneal dialysis group. At 120 h, the mean change in the creatinine level was 1.4 ± 0.5 mg/dL in the ultrafiltration therapy group, as compared with 2.4 ± 1.3 mg/dL in the tidal peritoneal dialysis group (p = 0.023). At 72 and 120 h, there was a significant difference in weight loss between patients in the ultrafiltration therapy group and those in the tidal peritoneal dialysis group (p = 0.025). Net fluid loss was also greater in tidal peritoneal dialysis patients (p = 0.018). Adverse events were more observed in the ultrafiltration therapy group (p = 0.007). At 90 days post-discharge, tidal peritoneal dialysis patients had fewer rehospitalization for heart failure (14.3% vs 32.5%, p = 0.022).
Conclusion:
Tidal peritoneal dialysis is a safe and effective means for removing toxins and large quantities of excess fluid from patients with intractable heart failure. In patients with cardiorenal syndrome type 1, the use of tidal peritoneal dialysis was superior to ultrafiltration therapy for the preservation of renal function, improvement of cardiac function, and net fluid loss. Ultrafiltration therapy was associated with a higher rate of adverse events.
RoncoCCicoiraMMcCulloughPA.Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol2012; 60: 1031–1042.
2.
MetraMDavisonBBettariL, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail2012; 5: 54–62.
3.
BagshawSMCruzDNAspromonteN, et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant2010; 25: 1406–1416.
4.
FormanDEButlerJWangY, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol2004; 43: 61–67.
5.
SmithGLLichtmanJHBrackenMB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol2006; 47: 1987–1996.
6.
DammanKNavisGVoorsAA, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail2007; 13: 599–608.
7.
TangWHMullensW.Cardiorenal syndrome in decompensated heart failure. Heart2010; 96: 255–260.
8.
BlairJEPangPSSchrierRW, et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J2011; 32: 2563–2572.
9.
DammanKJaarsmaTVoorsAA, et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail2009; 11: 847–854.
10.
FonarowGCAdamsKFJrAbrahamWT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA2005; 293: 572–580.
11.
AronsonDHammermanHBeyarR, et al. Serum blood urea nitrogen and long-term mortality in acute ST-elevation myocardial infarction. Int J Cardiol2008; 127: 380–385.
12.
AronsonDMittlemanMABurgerAJ.Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med2004; 116: 466–473.
13.
KleinLMassieBMLeimbergerJD, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict post-discharge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail2008; 1: 25–33.
14.
KazoryA.Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol2010; 106: 694–700.
JentzerJCDeWaldTAHernandezAF.Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol2010; 56: 1527–1534.
17.
AspromonteNCruzDNValleR, et al. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Expert Opin Drug Metab Toxicol2011; 7: 1049–1063.
18.
TestaniJMChenJMcCauleyBD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation2010; 122: 265–272.
19.
AspromonteNCruzDNValleR, et al. Management and monitoring of hemodynamic complications in acute heart failure. Heart Fail Rev2011; 16: 575–581.
20.
CruzDN.Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndrome. Adv Chronic Kidney Dis2013; 20: 56–66.
21.
KazoryARossEA.Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation2008; 117: 975–983.
22.
CostanzoMRGuglinMESaltzbergMT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol2007; 49: 675–683.
23.
KazoryA.Peritoneal dialysis for chronic cardiorenal syndrome: lessons learned from ultrafiltration trials. World J Cardiol2015; 7: 392–396.
24.
NúñezJGonzálezMMiñanaG, et al. Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail2012; 14: 540–548.
25.
CourivaudCKazoryA.Can we treat fluid overload with fluid? Role of peritoneal dialysis in management of heart failure. Eur J Heart Fail2012; 14: 461–463.
26.
CourivaudCKazoryACrépinT, et al. Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int2014; 34: 100–108.
27.
MehtaRLKellumJAShahSV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care2007; 11: R31.
28.
Al-HwieshAK.Peritoneal dialysis catheter insertion by a nephrologist: a new, simple and safe technique. Perit Dial Int2014; 34: 204–211.
29.
DerrickBWhiteP.Comparing two samples from an individual Likert question. Int J Math Stat2017; 18: 1–13.
30.
GrantSAitchisonTHendersonE, et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest1999; 116: 1208–1217.
31.
LogeartDTabetJYHittingerL, et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol2008; 127: 228–232.
32.
MetraMNodariSParrinelloG, et al. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail2008; 10: 188–195.
33.
LatchamsettyRFangJKline-RogersE, et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol2007; 99: 939–942.
34.
ParikhCRCocaSGWangY, et al. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med2008; 168: 987–995.
35.
NewsomeBBWarnockDGMcClellanWM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med2008; 168: 609–616.
36.
BartBAGoldsmithSRLeeKL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med2012; 367: 2296–2304.
37.
CarressHFLalaAMcNultySE, et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOS-HF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARRESS-HF). Circ Heart Fail2015; 8: 741–748.
38.
WeinfeldMSChertowGMStevensonLW.Aggravated renal dysfunction during intensive therapy for advanced heart failure. Am Heart J1999; 138: 285–290.
39.
KnightELGlynnRJMcIntyreKM, et al. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J1999; 138: 849–855.
40.
PhilbinEFCottoMRoccoTAJr, et al. Association between diuretic use, clinical response and death in acute heart failure. Am J Cardiol1997; 80: 519–522.
41.
NeubergGWMillerABO’ConnorCM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J2002; 144: 31–38.
42.
UngarAFumagalliSMariniM, et al. Renal but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med2004; 32: 1125–1129.
43.
McIntyreCW.Haemodialysis-induced myocardial stunning in chronic kidney disease: a new aspect of cardiovascular disease. Blood Purif2010; 29: 105–110.
44.
SelbyNMBurtonJOChestertonLJ, et al. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol2006; 1: 1216–1225.
45.
SelbyNMLambieSHCamiciPG, et al. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis2006; 47: 830–841.
46.
McIntyreCWBurtonJOSelbyNM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol2008; 3: 19–26.
47.
SelbyNMMcIntyreCW.Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int2011; 31: 27–33.
48.
BurtonJOJefferiesHJSelbyNM, et al. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol2009; 4: 1925–1931.
49.
LangSMBergnerATöpferM, et al. Preservation of residual renal function in dialysis patients: effects of dialysis-technique related factors. Perit Dial Int2001; 21: 52–57.
50.
MisraMVoneshEVan StoneJC, et al. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int2001; 59: 754–763.
51.
MoistLMPortFKOrzolSM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol2000; 11: 556–564.
52.
PonceDGoesCOliveiraM, et al. Peritoneal dialysis for the treatment of cardiorenal syndrome type 1: a prospective Brazilian study. Perit Dial Int2017; 37: 578–583.
53.
MullensWAbrahamsZFrancisGS, et al. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail2008; 14: 508–514.
54.
MullensWAbrahamsZSkouriHN, et al. Elevated intra-abdominal pressure in acute decompensated heart failure. J Am Coll Cardiol2008; 51: 300–306.
